Takuya Murata
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Takuya Murata has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Naoko Utsunomiya-Tate
Department of Biomolecular Chemistry, Faculty of Pharmaceutical Sciences, Teikyo University, Tokyo 173-8605, Japan
2 shared publications - Genta Ito
Department of Biomolecular Chemistry, Faculty of Pharmaceutical Sciences, Teikyo University, Tokyo, Japan
1 shared publication Naoya Tochio
Department of Biomolecular Chemistry, Faculty of Pharmaceutical Sciences, Teikyo University, 2-11-1, Kaga, Itabashi-ku, Tokyo 173-8605, Japan
1 shared publication- Noriko Isoo
Department of Physiology, School of Medicine, Teikyo University, Tokyo 173-8605, Japan
1 shared publication - Toshihiro Hayashi
Department of Neurology, The University of Tokyo, Tokyo, Japan
1 shared publication
Latest Publications
- Open Access
- 13 January 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (1) , 143
Site-Specific Aspartic Acid d-Isomerization in Tau R2 and R3 Peptide Seeds Attenuates Seed-Induced Fibril Formation of Full-Length Tau
The aggregation of tau protein is a central pathological event in Alzheimer’s disease, and this pathology is hypothesized to spread via a prion-like mechanism driven by tau “seeds”. While aggregated tau from Alzheimer’s disease brains is known to contain age-related d-isomerized aspartic acid (d-Asp) residues, it remains unknown how this modification affects the seeding activity that drives disease propagation. Here, we investigated the impact of site-specific d-isomerization within R2 and R3 tau repeat-domain peptides, which form the core of tau fibrils. We demonstrate that the stereochemical integrity of these peptides is critical for their seeding function. d-isomerization at Asp314 within the R3 peptide seed severely impaired its ability to template the fibrillization of full-length tau in vitro. This finding was validated in a cellular model, where R3 seeds containing d-Asp314 were significantly less potent at inducing the formation of phosphorylated tau aggregates compared to wild-type seeds. Our results establish that Asp d-isomerization within tau seeds acts as a potent attenuator of their pathological seeding activity, suggesting this spontaneous modification may intrinsically modulate the progression of Alzheimer’s disease.
- 13 January 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (1) , 143
Open AccessSite-Specific Aspartic Acid d-Isomerization in Tau R2 and R3 Peptide Seeds Attenuates Seed-Induced Fibril Formation of Full-Length Tau
The aggregation of tau protein is a central pathological event in Alzheimer’s disease, and this pathology is hypothesized to spread via a prion-like mechanism driven by tau “seeds”. While aggregated tau from Alzheimer’s disease brains is known to contain age-related d-isomerized aspartic acid (d-Asp) residues, it remains unknown how this modification affects the seeding activity that drives disease propagation. Here, we investigated the impact of site-specific d-isomerization within R2 and R3 tau repeat-domain peptides, which form the core of tau fibrils. We demonstrate that the stereochemical integrity of these peptides is critical for their seeding function. d-isomerization at Asp314 within the R3 peptide seed severely impaired its ability to template the fibrillization of full-length tau in vitro. This finding was validated in a cellular model, where R3 seeds containing d-Asp314 were significantly less potent at inducing the formation of phosphorylated tau aggregates compared to wild-type seeds. Our results establish that Asp d-isomerization within tau seeds acts as a potent attenuator of their pathological seeding activity, suggesting this spontaneous modification may intrinsically modulate the progression of Alzheimer’s disease.
- 1 August 2021
- Published by Elsevier in Neuroscience Letters
- Vol. 760, 136077
Physicochemical characterization of the G51D mutation of α-synuclein that is responsible for its severe cytotoxicity
- 1 August 2021
- Published by Elsevier in Neuroscience Letters
- Vol. 760, 136077
Physicochemical characterization of the G51D mutation of α-synuclein that is responsible for its severe cytotoxicity